Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Etomidate revisited.

P Ostwald1, A W Doenicke

  • 1Institute of Anaesthesiology, Ludwig-Maximilians-University, Munich, Germany. ostwald@lrz.uni-muenchen.de

Current Opinion in Anaesthesiology
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of a daily online implanted fiducial marker-guided prostate radiotherapy process.

Journal of medical imaging and radiation oncology·2008
Same author

Premedication with H1 and H2 blocking agents reduces the incidence of postoperative nausea and vomiting.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2004
Same author

Propofol in an emulsion of long- and medium-chain triglycerides: the effect on pain.

Anesthesia and analgesia·2001
Same author

Solvent for etomidate may cause pain and adverse effects.

British journal of anaesthesia·2000
Same author

Reducing myoclonus after etomidate.

Anesthesiology·1999
Same author

Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration.

Anesthesia and analgesia·1998
Same journal

Phrenic-sparing strategies for shoulder surgery: balancing respiratory safety and block completeness.

Current opinion in anaesthesiology·2026
Same journal

The evolution of nonoperating room anesthesia: navigating a new frontier.

Current opinion in anaesthesiology·2026
Same journal

Enhanced recovery pathways for patients with chronic pain: beyond standard protocols - a narrative review.

Current opinion in anaesthesiology·2026
Same journal

Novel technologies and innovations in postoperative follow-up after regional anesthesia.

Current opinion in anaesthesiology·2026
Same journal

Regional anaesthesia and analgesia in surgical patients with chronic preoperative pain: mechanisms, evidence, and clinical implications.

Current opinion in anaesthesiology·2026
Same journal

Retention in pain care and research: a narrative review focused on implanted medical devices.

Current opinion in anaesthesiology·2026
See all related articles

Etomidate offers cardiovascular stability and potential neuroprotection, but causes adrenal suppression and myoclonus. Recent advances include a new formulation and pretreatment to mitigate side effects.

Area of Science:

  • Anesthesiology and Pharmacology

Background:

  • Etomidate is an anesthetic agent known for its lack of cardiovascular side effects.
  • It is also suggested to possess neuroprotective properties.
  • However, known side effects include adrenal suppression and myoclonus.

Purpose of the Study:

  • To review recent literature on etomidate.
  • To discuss its clinical applications, adverse effects, and mechanism of action.

Main Methods:

  • A comprehensive literature review was conducted.

Main Results:

  • Recent advancements include a new etomidate preparation free from propylene glycol and its associated side effects.
  • A novel pretreatment method has been developed to potentially decrease the occurrence of myoclonus.

Related Experiment Videos

  • The specific site of action for etomidate within the central nervous system has been identified.

    • Conclusions:

    • Etomidate remains a valuable anesthetic due to its hemodynamic stability.
    • Ongoing research is addressing its side effect profile, particularly adrenal suppression and myoclonus.
    • Advances in formulation and administration aim to improve patient outcomes and expand its clinical utility.